Big Pharma Earnings Watch: Johnson & Johnson

04-14-2020 Blog Posts

Price Hikes Fuel Better Than Expected Earnings For Brand Name Giant As millions of Americans struggle to afford their medications amid unprecedented health care and economic challenges, the first earnings report from a Big Pharma giant demonstrates that hiking prices on American patients continues to be a profitable practice for the industry. Today, brand name […]

CSRxP: New Study Undercuts Bogus Net Price Refrain From Big Pharma

03-4-2020 Blog Posts

Brand Name Drug Companies Repeated List Price Hikes Lead to Higher Net Prices   For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday in response to a new study which found brand name drug companies’ list price increases have led to overall […]

Big Pharma Watch: Brand Name Drug Giant Caught Red Handed In Anti-Competitive Kickback Scheme

03-3-2020 Blog Posts

Sanofi Demonstrates How Brand Name Drug Companies Use Nonprofits to Keep Prices High & Pad Their Bottom Line Providing the latest example of the extremes Big Pharma will pursue in order boost their bottom-line, brand name drug giant Sanofi was recently caught exploiting charities at the expense of taxpayers. In a settlement announced last week, […]

What They Are Saying: Americans Continue to Demand Bipartisan Solutions to Hold Big Pharma Accountable, Lower Rx Prices

03-2-2020 Blog Posts

Voices from Around the Country Reiterate Need for Congress to Address Out-of-Control Prescription Drug Prices in 2020 Prescription drug prices are out-of-control and have left 58 million Americans struggling to afford their much-needed medications. Meanwhile, Big Pharma continues to evade responsibility for the crisis it created by hiking prices and gaming the system. Americans across […]

Q4 EARNINGS: BIG PHARMA PRICE HIKES KEEP THE GOOD TIMES ROLLING

02-18-2020 Blog Posts

Top Brand Name Drug Companies Bank Sky-High Profits While Evading Accountability   And that’s a wrap! Over three weeks of earnings calls have proven, yet again, that hiking prices is a profitable practice for an industry more concerned with pleasing its shareholders than helping patients. This quarter, CSRxP tracked earnings reports from 12 of the […]

BIG PHARMA EARNINGS WATCH: ASTRAZENECA

02-14-2020 Blog Posts

Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Banked Sky-High Profits After Hiking Prices Earnings reports for the fourth quarter of 2019 provide the latest evidence that Big Pharma continues to bank sky-high profits while price-gouging American patients. Today, brand name drug giant AstraZeneca announced rising profits completing a trend that holds […]

BIG PHARMA EARNINGS WATCH: ABBVIE

02-10-2020 Blog Posts

Big Pharma Giant Bests Wall Street Expectations After Hiking Prices In January   Yet another brand name drug company announced last week it had surpassed earnings expectations after hiking prices on American patients. On Friday, Big Pharma giant AbbVie reported sky-high profits after enacting a series of price hikes throughout 2019. AbbVie reported 4th quarter […]

BIG PHARMA EARNINGS WATCH: MERCK, GLAXOSMITHKLINE & BRISTOL-MYERS SQUIBB

02-7-2020 Blog Posts

Brand Name Drug Companies Keep the Good Times Rolling for Shareholders by Price-Gouging American Patients This week, three more Big Pharma giants proved yet again that hiking prices is a profitable practice for an industry more concerned with pleasing its shareholders than helping patients.  Merck, GlaxoSmithKline (GSK) and Bristol-Myers Squibb all reported sky-high profits this […]

BIG PHARMA WATCH: ANTI-COMPETITIVE CHARITY SCHEMES TAKE CENTER STAGE AT WAYS & MEANS HEARING

02-6-2020 Blog Posts

Testimony Highlights How Brand Name Drug Companies Use Nonprofits To Keep Prices High & Pad Their Bottom Line   Expert witnesses at a Wednesday hearing before the U.S. House of Representatives Committee on Ways & Means Subcommittee on Health highlighted how Big Pharma exploits nonprofit charities as a vehicle to boost their bottom line. Ge Bai, […]

DOSE OF REALITY: BIG PHARMA’S INSULIN PRICE PREDICAMENT

02-4-2020 Blog Posts

Pharmaceutical Companies to Blame for Out-of-Control Prices for Life-Saving Drug   During tonight’s State of the Union address, President Trump is expected to address the mounting crisis of affordability caused by the out-of-control price of prescription drugs. One drug in particular has been at the forefront of this crisis for millions of Americans diagnosed with […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.